Agilon Health, Inc. Form 8-K Summary
Business Context and Reporting Period
This Current Report on Form 8-K covers events occurring on March 17, 2026, and March 18, 2026. Agilon Health, Inc. (AGL) held a special meeting of stockholders to vote on corporate governance matters, specifically regarding a reverse stock split.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses exclusively on corporate actions and voting results rather than financial performance.
Material Changes and Corporate Actions
- Reverse Stock Split Approval: Stockholders approved an amendment to the Certificate of Incorporation to effect a reverse stock split with a ratio between 1-for-5 and 1-for-25.
- Voting Results (Proposal 1): 356,574,789 votes For; 6,187,388 votes Against; 365,864 votes Abstained.
- Adjournment Approval: Stockholders approved the adjournment of the meeting if necessary to solicit further votes.
- Final Ratio Determination: On March 18, 2026, the Board of Directors set the specific reverse stock split ratio at 1-for-25.
- Implementation Date: The split is scheduled to become effective at 5:00 p.m. Eastern Time on March 30, 2026, upon filing the Certificate of Amendment with the Delaware Secretary of State.
Outlook, Risks, and Management Commentary
Management has confirmed the implementation of the 1-for-25 reverse stock split. The filing does not contain specific forward-looking guidance, risk factors, or contingencies beyond the standard execution of the approved corporate action.
Key Facts for Investor Verification
- Verify the exact effective time of the 1-for-25 reverse stock split (March 30, 2026, 5:00 p.m. ET).
- Confirm the filing of the Certificate of Amendment with the Delaware Secretary of State.
- Monitor the post-split trading price and share count adjustments on the New York Stock Exchange.
- Review the attached press release (Exhibit 99.1) for additional details on the rationale for the split.